详情页 - 广东省中医院知识库

当前位置：首页 > 详情页

Effects of acupoint therapy on nonalcoholic fatty liver disease: A systematic review and meta-analysis

12| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [a]School of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China [b]Department of Endocrinology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China

出处：

DOI：

ISSN：

关键词： Acupuncture Blood lipids Meta-analysis Nonalcoholic fatty liver disease Transaminase

摘要：

Background: and purpose: Acupoint therapy is suggested as a potential intervention for treating nonalcoholic fatty liver disease (NAFLD). This review assessed current evidence for the effect of acupoint therapy on NAFLD. Methods: Eight electronic databases were searched to identify randomized controlled trials (RCTs) of patients with NAFLD treated by acupoint therapy from their inception to August 2020. A meta-analysis of outcomes was conducted by RevMan 5.3. Results: Sixteen RCTs with 1320 patients were included. Acupoint therapy was significantly associated with improvements in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. Additionally, acupoint therapy significantly reduced triglyceride (TG), total cholesterol (TC) and low-density lipoprotein (LDL) levels. High-density lipoprotein (HDL) levels were also increased in NAFLD patients. Conclusion: Compared with other treatments, acupoint therapy may improve liver function and lipid metabolism, making it an available treatment for NAFLD. However, these findings need to be confirmed in large-scale, rigorously designed RCTs. © 2021 Elsevier Ltd

基金：

语种：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 4 区医学

小类 | 4 区全科医学与补充医学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区全科医学与补充医学

JCR分区：

出版当年[2019]版：

Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE

最新[2023]版：

Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE

影响因子： 2.2 最新[2023版] 2.8 最新五年平均 1.77 出版当年[2019版] 2.073 出版当年五年平均 1.587 出版前一年[2018版] 2.446 出版后一年[2020版]

第一作者：

第一作者机构： [a]School of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis [2]Establishment and Comparison of Juvenile Female Mouse Models of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis [3]Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy [4]Establishment and comparison of juvenile female mouse models of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis(Open Access) [5]Efficacy and safety of Yinchenwuling Powder for nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis of randomized controlled trials [6]Vitexin ameliorates chronic stress plub high fat diet-induced nonalcoholic fatty liver disease by inhibiting inflammation. [7]Si-Wu-Tang Alleviates Nonalcoholic Fatty Liver Disease via Blocking TLR4-JNK and Caspase-8-GSDMD Signaling Pathways. [8]Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver disease [9]Hugan Qingzhi Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease. [10]Bioinformatics study of the potential therapeutic effects of ginsenoside Rf in reversing nonalcoholic fatty liver disease.